Alert: Pharma Escalates Psychedelic Ad Spend; Medicaid Coverage & Ibogaine Funding Advances

Pharmaceutical companies are significantly increasing their Google ad spend on psychedelic-related keywords, primarily promoting regulated treatments like J&J's Spravato, indicating growing mainstream market activity. Concurrently, ARPA-H is funding ibogaine trials, and discussions are advancing regarding potential Medicaid coverage for psychedelic therapies, pointing towards expanding access and regulation for these substances.